Alacrita welcomes Dr Li Zeng to the team. Having trained as a surgeon in China and Europe, Li joined Baxter Hyland Immuno where she helped register fibrin sealant and albumin in China.
From 2001 to 2008, Li worked as Clinical Scientist and Global SMT Leader for Roche Pharmaceutical Division in Basel, being involved in several global Phase III and IV development programmes.
In 2008, she moved back to Beijing where she coordinates and leads product registrations and advises clients on their Chinese development strategy.
Li qualified in Medicine at the Hunan Medical University, where she also completed her surgical training. She trained in pharmaceutical medicine at ECPM, University of Basel.